Fexofenadine hydrochloride vs Mepolizumab
National NHS prescribing compared (Prescription Cost Analysis)
Fexofenadine hydrochloride was dispensed 621,716.0× as often as Mepolizumab in March 2026 — 621,716 items versus 1 in England.
621,716items
Fexofenadine hydrochloride · March 2026
NHSBSA Prescription Cost Analysis
1items
Mepolizumab · March 2026
NHSBSA Prescription Cost Analysis
Figure 1. Fexofenadine hydrochloride versus Mepolizumab: national items dispensed by month
▬ Fexofenadine hydrochloride · ╌ Mepolizumab
Source: NHSBSA Prescription Cost Analysis, to March 2026
| Measure | Fexofenadine hydrochloride | Mepolizumab |
|---|---|---|
| Items, March 2026 | 621,716 | 1 |
| Items, last 12 months | 7,058,089 | 2 |
| Net ingredient cost, March 2026 | £2,288,270 | £3,360 |
See the full profile for Fexofenadine hydrochloride or Mepolizumab.